Efficacy of Combined Pembrolizumab and Bevacizumab in Platinum-Resistant Nasopharyngeal Carcinoma
Nasopharyngeal carcinoma (NPC) is common in South China and parts of Southeast Asia. Despite treatment, 20-30% of patients relapse within five years and ultimately become resistant to standard platinum-based chemotherapy; […]
Revolutionising Nanomedicine: DNA Barcodes for Gold Nanoparticles
Gold nanoparticles (NPs) are promising for cancer therapy due to their versatile properties. However, their interactions with cells vary, affecting reproducibility and application. To optimise this, Dr Andy Tay Kah […]
Magnetic Field Therapy Improves Breast Cancer Treatment with Fewer Side Effects
Chemotherapy, although the first line of defense in cancer treatment, is indiscriminate and is damaging to the entire body, which, ironically, worsens a patient’s chances of getting better from cancer. […]
New CAR T-Cell Therapy Offers Hope for Relapsed or Refractory T-cell Leukaemia
Relapsed/refractory T-cell acute lymphoblastic leukemia (T-ALL) is challenging to treat. Outcome for such patients is dismal. A recent experimental treatment – using CD7 CAR T-cell therapy, developed by N2CR member […]
Clinical Trial Shows Promise in Treating Advanced Gastric Cancer
A recent phase l trial evaluated the safety and efficacy of combining pressurised intraperitoneal aerosol chemotherapy-oxaliplatin (PIPAC-OX) with nivolumab in patients with gastric cancer peritoneal metastases (GCPM). Eighteen patients from […]
N2CR researchers uncover a missing link between poor diet and higher cancer risk
N2CR researchers led by Prof Ashok Venkitaraman and Dr Kong Li Ren have unearthed new findings which may help explain the connection between cancer risk and poor diet, as well […]
Novel stem cell therapy for cancer-stricken pets
N2CR member, A/Prof Too Heng-Phon, Dr Sarah Ho and team have developed a way to use stem cells to treat cancer in cats and dogs, a method originally developed for […]